Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing immunization coverage: how and why?

N Guérin1

  • 1International Centre for Childhood and the Family, Paris, France. efe@cidef.org

Vaccine
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Synofast® in routine rheumatology practice: diagnostic performance and impact on management of an acute arthritis.

Advances in rheumatology (London, England)·2025
Same author

Immunisation schedules in the countries of the European Union.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same author

Volumetric evaluation of fat resorption after breast lipofilling.

Annales de chirurgie plastique et esthetique·2015
Same author

[Is the new vaccination schedule recommended in France adapted to premature babies?].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Same author

[Plea for advancement of the age of vaccination against human papillomavirus in France: Position of the Pediatric Infections Pathology Group (GPIP) and the French Association of Ambulatory Pediatrics (AFPA)].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2012
Same author

[Severe thoracic radionecrosis: muscle-sparing latissimus dorsi flap (MSLD)].

Annales de chirurgie plastique et esthetique·2012
Same journal

V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.

Vaccine·2026
Same journal

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.

Vaccine·2026
Same journal

Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.

Vaccine·2026
Same journal

Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.

Vaccine·2026
Same journal

Public health benefits of maternal influenza vaccination among pregnant women and infants <6 months in the United States, 2011-2020.

Vaccine·2026
Same journal

Effectiveness and acceptability of an opt-out nudge to promote influenza vaccination among medical residents: A randomized controlled trial.

Vaccine·2026
See all related articles

Evaluating immunization programs requires accurate coverage assessment at national and district levels. Routine methods in EU countries need regular validation through specific surveys to ensure reliability.

Area of Science:

  • Public Health
  • Epidemiology
  • Health Services Research

Background:

  • Immunization coverage assessment is crucial for evaluating public health programs.
  • Effective program management and decision-making rely on accurate coverage data.
  • Current routine methods in European Union (EU) countries exhibit variability and potential inaccuracies.

Purpose of the Study:

  • To emphasize the importance of immunization coverage assessment.
  • To highlight the necessity of conducting assessments at both national and district levels.
  • To advocate for the validation of routine methods through specific surveys.

Main Methods:

  • The abstract discusses the general principles of coverage assessment.
  • It implies a review or analysis of existing routine methods in EU countries.

Related Experiment Videos

  • It recommends the use of specific surveys for validation.

    • Main Results:

    • Routine immunization coverage assessment is vital for program evaluation.
    • National and district level assessments are recommended.
    • Existing routine methods in EU countries require validation.

    Conclusions:

    • Regular validation of routine immunization coverage assessment methods is essential.
    • Specific surveys are necessary to ensure the accuracy of coverage data.
    • Accurate data supports effective immunization program management and decision-making.